Advertisement
U.S. markets closed

Arrowhead Pharmaceuticals, Inc. (ARWR)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
28.60-0.10 (-0.35%)
At close: 04:00PM EDT
28.60 0.00 (0.00%)
After hours: 06:58PM EDT
Currency in USD
Earnings EstimateCurrent Qtr. (Mar 2024)Next Qtr. (Jun 2024)Current Year (2024)Next Year (2025)
No. of Analysts12121312
Avg. Estimate-0.16-0.63-2.67-2.63
Low Estimate-0.95-0.95-4.07-3.98
High Estimate3.27-0.24-1.26-1.46
Year Ago EPS0.45-0.96-1.92-2.67
Revenue EstimateCurrent Qtr. (Mar 2024)Next Qtr. (Jun 2024)Current Year (2024)Next Year (2025)
No. of Analysts10111313
Avg. Estimate63.87M29.52M139.03M157.94M
Low EstimateN/AN/A53.55MN/A
High Estimate250M75.5M302M286.1M
Year Ago SalesN/AN/A240.74M139.03M
Sales Growth (year/est)N/AN/A-42.20%13.60%
Earnings History3/30/20236/29/20239/29/202312/30/2023
EPS Est.-0.64-0.65-0.6-0.82
EPS Actual0.45-0.96-1.02-1.24
Difference1.09-0.31-0.42-0.42
Surprise %170.30%-47.70%-70.00%-51.20%
EPS TrendCurrent Qtr. (Mar 2024)Next Qtr. (Jun 2024)Current Year (2024)Next Year (2025)
Current Estimate-0.16-0.63-2.67-2.63
7 Days Ago-0.16-0.63-2.67-2.63
30 Days Ago-0.16-0.63-2.67-2.63
60 Days Ago-0.39-0.83-3.25-3.24
90 Days Ago-0.41-0.85-3.29-3.17
EPS RevisionsCurrent Qtr. (Mar 2024)Next Qtr. (Jun 2024)Current Year (2024)Next Year (2025)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 DaysN/AN/AN/AN/A
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Growth EstimatesARWRIndustrySector(s)S&P 500
Current Qtr.-135.60%N/AN/AN/A
Next Qtr.34.40%N/AN/AN/A
Current Year-39.10%N/AN/AN/A
Next Year1.50%N/AN/AN/A
Next 5 Years (per annum)7.33%N/AN/AN/A
Past 5 Years (per annum)N/AN/AN/AN/A